BLOG/🇺🇸United States··daily

S&P 500 Consumer Staples Sector SEC Filings — March 04, 2026

USA S&P 500 Consumer Staples

25 high priority25 medium priority50 total filings analysed

Executive Summary

Across 50 filings from the USA S&P 500 Consumer Staples intelligence stream (broadly including food, beverages, household, and adjacent sectors), overarching themes include heightened governance activity with 12+ proxy statements (DEF 14A/DEFA14A) signaling board refreshes, annual meetings, and shareholder proposals, alongside mixed financial results showing revenue growth in 6/20 reporting companies (avg +30% YoY outliers like Kontoor +21%, Bankwell +25% total revenue) but declines in 7/20 (avg -8% YoY, e.g., Cracker Barrel -7.9%). Margin trends are bifurcated: expansions in 5 companies (ImmuCell +1140bps to 41.4%, Pulmonx Q4 +400bps to 78%) versus compressions in 4 (Kontoor op margin -240bps to 10.7%). Capital allocation leans defensive with steady dividends (Horizon $0.06/month, Helmerich $0.25/quarter) and buybacks (Kontoor repurchased at $67.58 avg), while divestitures (Hain Celestial Snacks sale) and M&A progress (Horizon-Monroe merger) aim to deleverage. Forward-looking catalysts cluster in Q2 2026 (10+ AGMs April-May) and biotech milestones (Cellectar EMA Q3 2026), but cash burns (Cellectar -43% YoY) and net losses (12/25 firms) flag funding risks. Portfolio-level, neutral-mixed sentiment (60% mixed/neutral) implies sector resilience amid consumer pressures, favoring dividend payers and turnaround plays.

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from March 03, 2026.

Investment Signals(12)

  • Product sales +4.3% YoY to $27.6M, gross margin +1140bps to 41.4%, EBITDA +100% to $2.2M, cash from ops +525% to $2.5M

  • FY2025 net revenues +21% YoY to $3.15B (Helly Hansen $476M contrib), gross margin +70bps to 45.2%, Wrangler revenue +6% & margin +270bps to 23.0%, $25M buyback remaining

  • Net income +260% YoY to $35.2M, total revenue +25% to $108.3M, provision for losses -96% to $1.0M, ROA +780bps to 1.09%, NPAs -1390bps to 0.49%

  • Completed Snacks divestiture (Garden Veggie, Terra) to reduce debt & leverage, sharpening focus on higher-margin yogurt/tea/baby foods

  • Elutia Inc(BULLISH)

    Regained Nasdaq Minimum Bid Price ($1+ for 10 days Feb13-27 2026) & MVLS ($35M+ for 11 days Jan21-Feb4 2026) compliance

  • Horizon Technology Finance(BULLISH)

    Q4 NII $0.18/share despite -33% YoY dip, debt yield 14.3%, monthly $0.06/share dividends Apr-Jun 2026, Monroe merger to boost NII/NAV

  • FY2025 revenue +8% YoY (intl +23%), gross margin stable 74%, op ex -11% Q4, FY2026 guidance $90-92M revenue/75% margin, refinanced $60M debt to 2031

  • PepGen Inc(BULLISH)

    Cash +22.5% to $60.5M (into 2H2027 post-Q4 $148.5M), net loss narrowed FY -0.3% to $89.7M & Q4 -18% to $18.3M, R&D -7% YoY

  • Extended credit facility to 2031 w/ $2.7B new vehicle floorplan +$2.4B revolver, removed SOFR adjustment

  • Low 0.3x senior leverage despite Q2 revenue -7.9% YoY, $46M Q3 litigation cash benefit, FY2026 EBITDA guide $85-100M, $0.25 dividend

  • R&D -56% & G&A -55% YoY, pipeline catalysts (EMA submission Q3 2026, FDA BTD, Phase 1b data mid-2026), Ac-225 supply secured

  • Declared $0.25/share quarterly dividend payable Jun1 2026 (record May18)

Risk Flags(9)

  • Q2 FY2026 revenue -7.9% YoY to $874.8M, net income -94% to $1.3M ($0.06/share), adj EBITDA -49% to $38.2M, 6-mo net loss $23.3M vs profit $27.1M

  • Cash -43% YoY to $13.2M (funds to Q3 2026), total assets -41% to $15.0M, net loss $21.8M ($8.35/share), shares +176% to 4.24M

  • Net loss $1.0M (imp $2.2M prior), Q4 loss $2.8M vs profit $0.5M, $2.7M Re-Tain write-down +$651k inventory

  • Op income -2% to $337M (margin -240bps to 10.7%), SG&A +320bps to 34.5% of rev, Lee brand revenue -5.1% & profit -23.1%

  • Horizon Technology / Portfolio Deterioration[MEDIUM RISK]

    NAV/share -17% YoY to $6.98, portfolio -7% to $647.2M, credit rating 2.9 (from 3.1), realized losses -$55.1M FY

  • Q4 2025 repurchases prorated to 3.6% due to funding cap, delays shareholder liquidity despite 5% annual limit

  • FDA partial hold on FREEDOM2 trial, G&A +6.2% YoY, shares +100%+ to 68.9M diluting EPS to -$2.12

  • United States 12 Month Nat Gas Fund / NAV Erosion[MEDIUM RISK]

    NAV/share -9.6% YoY to $7.34, avg daily assets -20.9% to $14.3M, unrealized losses $3.19M

  • CAO David Reiner terminated Feb27 2026

Opportunities(9)

Sector Themes(6)

  • Proxy/Governance Surge

    15/50 filings (30%) are DEF/DEFA14A (e.g., Celanese, Select Medical, Moody's AGMs Apr14-23 2026), w/ board declassifications, auditor rats, say-on-pay; signals activist pressure & refreshment, watch voting outcomes for control shifts

  • Margin Bifurcation in Consumer-Facing

    5/12 cos w/ margin expands (avg +500bps, ImmuCell outlier +1140bps) vs 4 compress (avg -200bps, Kontoor -240bps), tied to vol efficiencies vs SG&A bloat; favors ops-focused plays amid staple pricing power

  • Revenue Pressures in Retail/Food

    7/20 reporters show declines (avg -7% YoY, Cracker Barrel -7.9% comps -7.1%), offset by M&A (Kontoor +21%); implies defensive staples rotation to dividend payers (4 declarations, e.g., $0.06-0.25/share)

  • Cash Burn & Funding in Growth/Biotech

    6/15 adjacents (Cellectar -43%, PepGen shares +100%) cut R&D/G&A 5-56% but burn persists; offset by offerings/patents, pipeline catalysts Q1-Q3 2026 offer alpha for risk-tolerant

  • Deleveraging via Divest/M&A

    4 deals (Hain sale, Celanese Micromax div, Horizon-Monroe) reduce debt/leverage (Cracker 0.3x), prioritize FCF; cap alloc shifts to buybacks/divs (Kontoor $25M rem, Procaccianti capped)

  • Compliance/Listing Wins

    2 regains (Elutia bid/MVLS), reverse splits approved (ClearSign, Actelis proposals); undervalued small-caps post-Nasdaq fixes

Watch List(8)

  • Q3 2026 Conditional MA for iopofosine + Phase 1b data mid-2026; monitor cash burn post-$13.2M runway Q3 2026

  • Virtual vote on declassification (maj of 124M shares), special mtg threshold (25% vs 10% prop), list avail Apr10 [https://meetnow.global/MKMHXJW]

  • 9 directors, KPMG ratify, exec comp vote post-Micromax div & deleveraging [www.virtualshareholdermeeting.com/CE2026]

  • $46M litigation cash Q3, FY2026 EBITDA $85-100M guide amid -7.9% Q2 rev; watch traffic recovery

  • Moody's Corp / AGM Apr14 2026
    👁

    10 directors, KPMG 2026 audit, exec comp; record Feb18, materials Mar4 [www.virtualshareholdermeeting.com/MCO2026]

  • Horizon Technology / Monroe Merger
    👁

    Progress on NII/NAV boost, monthly divs thru Jun16 2026 (ex-dates Mar16+); Q1 update post-Q4 NII dip

  • Q1 2026 5mg/kg results + FDA hold resolution, cash to 2H2027; patent to 2042

  • Director retirement (Bacuvier), appt Uvashni Raman CFO Booking.com; succession watch

Filing Analyses(50)
SELECT MEDICAL HOLDINGS CORPDEF 14Aneutralmateriality 7/10

04-03-2026

Select Medical Holdings Corporation's DEF 14A proxy statement details the 2026 Annual Meeting procedures, with stockholders of record as of February 27, 2026 entitled to vote on 124,018,300 outstanding shares held by 134 registered holders. The Board of 10 directors (8 independent) recommends voting FOR director nominees, executive compensation approval, auditor ratification (PricewaterhouseCoopers LLP), board declassification amendment, and a 25% ownership threshold for special meetings, but AGAINST a stockholder proposal for a 10% threshold. The virtual meeting will be held at 11:00 a.m. EDT, accessible via https://meetnow.global/MKMHXJW.

  • ·Board held 8 meetings in fiscal year 2025; each director attended at least 75% of Board and committee meetings.
  • ·Annual Meeting stockholder list available for examination starting April 10, 2026 at company offices in Mechanicsburg, Pennsylvania.
  • ·Proposal 4 (board declassification) requires majority of outstanding shares; abstentions and broker non-votes count as negative votes.
  • ·Proposals 2, 3, 5, 6 require majority of shares present or by proxy; broker non-votes and abstentions have negative effect except for Proposal 1 (director elections by majority of votes cast).
Cellectar Biosciences, Inc.8-Kmixedmateriality 8/10

04-03-2026

Cellectar Biosciences reported 2025 financial results with cash and equivalents declining 43% to $13.2M from $23.3M, sufficient to fund operations into Q3 2026, alongside sharp reductions in R&D expenses (down 56% to $11.5M) and G&A (down 55% to $11.5M), resulting in a narrower net loss of $21.8M ($8.35/share) versus $44.6M ($36.52/share) in 2024. Pipeline advancements include plans for Q3 2026 Conditional Marketing Authorization submission to EMA for iopofosine I 131 in Waldenström Macroglobulinemia, FDA Breakthrough Therapy Designation, and initiation of a Phase 1b study for CLR 125 in triple negative breast cancer with data expected mid-2026. However, ongoing cash burn and lack of revenue underscore funding risks ahead of key milestones.

  • ·Common shares outstanding increased to 4,240,129 from 1,535,996 YoY.
  • ·Phase 1b CLR 125 study evaluates doses of 32.75 mCi/m²/dose (up to 4 cycles), 62.5 mCi/m²/dose (up to 3 cycles), and 95 mCi/m²/dose (up to 2 cycles).
  • ·Secured supply agreement with Ionetix for cGMP-grade Actinium-225 (Ac-225) and Astatine-211 (At-211).
IMMUCELL CORP /DE/8-Kmixedmateriality 8/10

04-03-2026

ImmuCell Corporation reported 2025 product sales of $27.6 million, up 4.3% YoY from $26.5 million, with gross margin expanding to 41.4% from 30% due to higher volumes (380,000 units/month vs. 345,000) and efficiencies, resulting in net operating income of $1.6 million versus a $1.6 million loss in 2024. However, the company posted a net loss of $1.0 million, improved from $2.2 million but driven by one-time charges including a $2.7 million Re-Tain asset write-down, $651,000 colostrum inventory write-down, and $297,000 CEO transition expenses; Q4 saw a net loss of $2.8 million versus a $0.5 million profit. Balance sheet showed stable cash at $3.8 million but a slight decline in stockholders' equity to $27.1 million from $27.5 million.

  • ·EBITDA for 2025 was $2.2 million vs. $1.1 million in 2024.
  • ·Cash from operating activities improved to $2.5 million in 2025 from $0.4 million in 2024.
  • ·Total assets decreased to $42.5 million as of Dec 31, 2025 from $45.1 million as of Dec 31, 2024.
  • ·Conference call scheduled for March 5, 2026 at 9:00 AM ET.
Celanese CorpDEF 14Amixedmateriality 8/10

04-03-2026

Celanese Corporation's DEF 14A proxy statement, filed March 4, 2026, solicits votes for the election of nine directors (Bruce E. Chinn, Edward G. Galante, Kathryn M. Hill, Deborah J. Kissire, Michael Koenig, Christopher Kuehn, Ganesh Moorthy, Kim K.W. Rucker, and Scott A. Richardson), ratification of KPMG LLP as independent auditors for 2026, and an advisory vote on executive compensation at the virtual annual meeting on April 16, 2026. Letters from Chair Edward G. Galante and CEO Scott Richardson highlight progress in strategic transformation, including the Micromax® divestiture to accelerate deleveraging and enhance free cash flow, alongside board refreshment with new directors. However, they acknowledge that important work remains to strengthen performance and shareholder value.

  • ·Annual meeting held virtually at www.virtualshareholdermeeting.com/CE2026
  • ·Record date for shareholder eligibility not specified in provided content
  • ·Board focuses on balance sheet strength, operational performance, and portfolio optimization
  • ·Shareholder engagement topics included board composition, governance, compensation, and sustainability
Celanese CorpDEFA14Aneutralmateriality 3/10

04-03-2026

Celanese Corporation (CE) filed a DEFA14A Definitive Additional Materials proxy statement on March 04, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. No fee was required for the filing, and it is marked as Definitive Additional Materials rather than preliminary or confidential.

  • ·Filing Type: DEFA14A (Schedule 14A)
  • ·Filed by the Registrant
CREDITRISKMONITOR COM INC8-Knegativemateriality 6/10

04-03-2026

CreditRiskMonitor.com, Inc. (CRMZ) announced the termination of Chief Accounting Officer David Reiner's position on February 27, 2026, with his last day being the same date. The company thanked Mr. Reiner for his service. The filing was signed by CEO and President Michael I. Flum on March 4, 2026.

MONROE CAPITAL Corp425positivemateriality 7/10

04-03-2026

Horizon Technology Finance Corporation (HRZN) announced monthly cash distributions of $0.06 per share for April, May, and June 2026, totaling $0.18 per share, payable on April 15, May 15, and June 16, 2026, respectively. Since its 2010 IPO, Horizon has distributed a total of $360M to shareholders. The board's decision factors in results of operations, spillover income, and the anticipated merger with Monroe Capital Corporation (MRCC), with no declines or flat metrics reported.

  • ·Ex-Dividend/Record Dates: March 16, 2026 ($0.06); April 16, 2026 ($0.06); May 18, 2026 ($0.06)
  • ·Payment Dates: April 15, 2026; May 15, 2026; June 16, 2026
  • ·Related SEC Registration Statement: File No. 333-290114
  • ·HRZN Proxy Statement filed April 17, 2025 (amended May 15, 2025); MRCC Proxy Statement filed April 21, 2025
Dakota Gold Corp.8-Kneutralmateriality 4/10

04-03-2026

Dakota Gold Corp. announced that its publicly traded warrants (DC.WS), each exercisable for one share of common stock at $2.08, will expire on March 15, 2026, with trading ceasing on or about March 13, 2026, ahead of NYSE American filing a Form 25 for delisting. The company's common stock (DC) will continue trading on NYSE American. This is a routine expiration event with no reported financial impact.

  • ·Warrants terms referenced from Form of Common Stock Purchase Warrant in S-1/A filed May 6, 2022
  • ·Company is an emerging growth company
  • ·Principal executive offices: 106 Glendale Drive, Suite A, Lead, South Dakota 57754
Kontoor Brands, Inc.10-Kmixedmateriality 9/10

04-03-2026

Kontoor Brands reported FY2025 net revenues of $3.15B, up 21% YoY from $2.61B, driven by the Helly Hansen acquisition ($476M), organic growth ($61M), and favorable FX ($8M); gross margin improved to 45.2% from 44.5%. However, operating income declined to $337M (10.7% margin) from $342M (13.1% margin) due to higher SG&A at 34.5% of revenues (vs 31.4%), with Wrangler up 6% in revenue but Lee down 5.1% with profit -23.1%. Helly Hansen contributed $460M revenue with 6.9% margin in its first year.

  • ·Repurchased 369,955 shares under public program at weighted avg $67.58/share, $190M remaining authorization.
  • ·SG&A expenses rose to 34.5% of revenues from 31.4%.
  • ·Wrangler operating margin expanded to 23.0% from 20.3%.
  • ·Other revenues surged 153% to $27.8M with margin turning positive at 13.7%.
Artificial Intelligence Technology Solutions Inc.8-Kpositivemateriality 4/10

04-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 4, 2026, announcing the issuance of a press release titled 'AITX's RAD Channel Partner Expands Detection to Guard Response Ecosystem,' attached as Exhibit 99.1. The filing discloses a positive development in channel partner expansion integrating detection capabilities into the Guard Response Ecosystem. No financial impacts or quantitative metrics were reported.

PROCACCIANTI HOTEL REIT, INC.8-Knegativemateriality 6/10

04-03-2026

Procaccianti Hotel REIT, Inc. announced on March 2, 2026, that share repurchases for the quarter ended December 31, 2025, under its Amended and Restated Share Repurchase Program are prorated due to the funding limitation being reached, with insufficient DRIP proceeds to fulfill all requests. Deceased stockholders' shares will be repurchased in full, but remaining requests will only be honored at approximately 3.6% pro rata, with no requests from qualifying disabilities or small accounts (≤100 shares). This reflects constraints under the program's 5.0% annual share limit and funding caps, potentially delaying liquidity for other shareholders.

  • ·Repurchase priorities: (1) deceased stockholders (full, pro rata if insufficient funds), (2) qualifying disabilities or involuntary exigent circumstances (e.g., bankruptcy) and small accounts ≤100 shares, (3) remaining requests pro rata.
  • ·Unfulfilled repurchase requests automatically carry over to subsequent periods unless withdrawn 5 business days prior to next repurchase date.
  • ·Death-related repurchases count toward 5.0% share limit but are exempt from percentage cap.
Pelican Acquisition CorpDEFA14Aneutralmateriality 6/10

04-03-2026

Pelican Acquisition Corporation filed a DEFA14A on March 4, 2026, announcing a Prospectus Supplement dated March 3, 2026, to the S-4 prospectus, clarifying that warrants of Pelican Holdco, Inc. (PubCo) will not be listed or traded on Nasdaq or any exchange. This update relates to the pending business combination with Greenland Exploration Limited and March GL Company, with no other changes to the prospectus. The filing serves as soliciting material ahead of the Pelican Shareholder Meeting to approve the transaction.

  • ·S-4 Registration Statement (No. 333-291171) declared effective February 17, 2026; original prospectus dated February 18, 2026.
  • ·Pelican 10-Qs filed for quarters ended October 31, 2025 (Dec 19, 2025), July 31, 2025 (Sep 15, 2025), April 30, 2025 (Jun 27, 2025); S-1 effective May 22, 2025.
  • ·Ordinary shares par value $0.0001 per share.
Pelican Acquisition Corp425neutralmateriality 3/10

04-03-2026

Pelican Acquisition Corporation filed a prospectus supplement on March 3, 2026, to the February 18, 2026 prospectus (part of S-4 Registration No. 333-291171), clarifying that PubCo's warrants will not be listed or traded on Nasdaq or any other exchange. This update relates to the ongoing business combination involving Pelican, Greenland Exploration Limited, March GL Company, and Pelican Holdco, Inc., with no other changes to the prospectus. Shareholders are directed to review the full materials for details on the Pelican Shareholder Meeting and related risks.

  • ·S-4 Registration No. 333-291171 declared effective February 17, 2026
  • ·Prospectus dated February 18, 2026
  • ·Pelican 10-Q filing dates: October 31, 2025 (December 19, 2025), July 31, 2025 (September 15, 2025), April 30, 2025 (June 27, 2025)
  • ·S-1 effective May 22, 2025
Pelican Acquisition Corp8-Kneutralmateriality 5/10

04-03-2026

Pelican Acquisition Corporation filed a Prospectus Supplement on March 3, 2026, to the S-4 prospectus dated February 18, 2026, clarifying that warrants of Pelican Holdco, Inc. (PubCo) will not be listed or traded on Nasdaq or any other exchange as part of the ongoing business combination with Greenland Exploration Limited and March GL Company. The supplement does not alter other aspects of the prospectus. Investors are directed to review the full Registration Statement (No. 333-291171), effective February 17, 2026, for details on the merger, including risks such as potential delays, redemptions, and failure to complete the transaction.

  • ·Registration Statement on Form S-4 (No. 333-291171) declared effective February 17, 2026.
  • ·Pelican 10-Q filings referenced: quarters ended October 31, 2025 (filed Dec 19, 2025), July 31, 2025 (filed Sep 15, 2025), April 30, 2025 (filed Jun 27, 2025); S-1 effective May 22, 2025.
  • ·Prospectus Supplement filed as Exhibit 99.1.
MOVING iMAGE TECHNOLOGIES INC.DEFA14Aneutralmateriality 5/10

04-03-2026

MOVING iMAGE TECHNOLOGIES INC. (MITQ) issued a DEFA14A additional proxy statement for its Annual Meeting of Stockholders on March 12, 2024, at 10:00 a.m. local time. Proposals include electing five directors for a one-year term expiring at the 2025 annual meeting and ratifying Haskell & White LLP as independent auditors for the fiscal year ending June 30, 2024. The Board recommends voting 'FOR' both proposals.

  • ·Meeting location: 17760 Newhope Street, Suite B, Fountain Valley, CA 92708
  • ·Fiscal year reference for audit ratification: ending June 30, 2024
  • ·Prior year reference: year ended June 30, 2023 (investor site link)
MOVING iMAGE TECHNOLOGIES INC.DEFA14Aneutralmateriality 4/10

04-03-2026

MOVING iMAGE TECHNOLOGIES INC. (MITQ) issued a DEFA14A proxy statement for its Annual Meeting of Stockholders scheduled for March 12, 2024, at 10:00 a.m. local time at its offices in Fountain Valley, CA. The meeting includes proposals to elect five directors for a one-year term until the 2025 annual meeting and to ratify Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2024. The Board of Directors recommends a vote 'FOR' both proposals.

  • ·Meeting location: 17760 Newhope Street, Suite B, Fountain Valley, CA 92708
  • ·Voting note: Cannot vote by returning this notice; follow provided instructions
  • ·Fiscal year reference: Ended June 30, 2023 (prior filings linked)
Movano Inc.425positivemateriality 8/10

04-03-2026

Corvex, Inc. announced on March 3, 2026, the verified production deployment of confidential computing for AI on NVIDIA HGX B200 systems, featuring encrypted GPU-to-GPU communication and remote attestation for secure AI workloads with near-native performance. This achievement supports secure multi-tenant AI environments and is highlighted in the context of Corvex's definitive all-stock merger agreement with Movano Inc. (Nasdaq: MOVE), announced on November 10, 2025. No financial metrics or performance comparisons were disclosed.

  • ·Definitive merger agreement (Merger Agreement) announced November 10, 2025
  • ·Form S-4 registration statement File No. 333-292321 contains proxy statement/prospectus
  • ·Merger is an all-stock transaction
  • ·Movano Commission File No.: 001-40254
  • ·Movano Annual Report on Form 10-K for year ended December 31, 2024
MONROE CAPITAL Corp425mixedmateriality 9/10

04-03-2026

Horizon Technology Finance (HRZN) reported Q4 2025 net investment income (NII) of $8.3M ($0.18 per share), down 20% and 33% YoY from $10.4M ($0.27 per share), with NAV per share declining 17% YoY to $6.98 amid distributions exceeding NII; total portfolio shrank 7% YoY to $647.2M but debt yield held at 14.3% (down 4% YoY) while full-year yield rose slightly to 15.8% from 15.6%. The company funded $102.5M across nine loans, built a $154M committed backlog, and noted progress on its planned merger with Monroe Capital Corporation (MRCC), which is expected to enhance future NII and NAV.

  • ·Weighted average credit rating declined to 2.9 from 3.1 YoY, with 4.1% of debt portfolio rated 1 (high risk of principal loss) at $24.5M fair value.
  • ·Net realized loss on investments worsened to $55.1M for FY 2025 from $34.6M in FY 2024.
  • ·Declared monthly distributions of $0.06 per share for April, May, and June 2026.
  • ·On Jan 12, 2026, funded $30M debt investment.
  • ·Net debt to equity leverage at 105%, below 120% target.
Cellectar Biosciences, Inc.10-Kmixedmateriality 8/10

04-03-2026

Cellectar Biosciences' total assets declined 41% YoY to $15.0M as of December 31, 2025 from $25.5M in 2024, driven by a 43% drop in cash and cash equivalents to $13.2M. While total liabilities improved 48% to $5.1M, highlighted by an 87% reduction in warrant liability to $0.23M, stockholders' equity fell 40% to $8.5M due to a $21.8M increase in accumulated deficit. Common shares outstanding more than doubled to 4.24M, with additional paid-in capital up 6% to $277M.

  • ·Filing date: March 04, 2026
  • ·Property, plant & equipment, net: $0.55M (2025) vs $0.76M (2024)
  • ·Operating lease right-of-use asset: $0.36M (2025) vs $0.44M (2024)
  • ·Accounts payable and accrued liabilities: $4.4M (2025) down 42% from $7.6M (2024)
Celanese Corp8-Kneutralmateriality 4/10

04-03-2026

On February 27, 2026, Timothy Go resigned from the Board of Directors of Celanese Corporation, effective as of that date. The resignation is not the result of any disagreement with the Company's operations, policies, or practices. The Board and Company expressed gratitude for Mr. Go’s service as a Director.

  • ·Filing date: March 4, 2026
  • ·Event reported date: February 27, 2026
  • ·Registrant state of incorporation: Delaware
  • ·Commission File Number: 001-32410
  • ·IRS Employer Identification No.: 98-0420726
ELUTIA INC.8-Kpositivemateriality 7/10

04-03-2026

Elutia Inc. announced on March 4, 2026, that it has regained compliance with Nasdaq's Minimum Bid Price Requirement, with its Class A common stock closing at $1.00 per share or higher for 10 consecutive business days from February 13 to February 27, 2026. The company also regained compliance with the Minimum Market Value of Listed Securities (MVLS) Requirement, achieving $35M or greater for 11 consecutive business days from January 21 to February 4, 2026. Both compliance matters, previously flagged in November and December 2025, are now closed.

  • ·Initial non-compliance notifications: Minimum Bid Price on November 7, 2025; MVLS on December 23, 2025.
  • ·Nasdaq determination letters: MVLS compliance on February 5, 2026; Minimum Bid Price on March 2, 2026.
  • ·Press release attached as Exhibit 99.1.
HEXCEL CORP /DE/8-Kneutralmateriality 7/10

04-03-2026

On March 3, 2026, Hexcel Corporation entered into a Cooperation Agreement with Vision One Fund, LP and affiliates, appointing Neal J. Keating to the Board of Directors and Audit Committee, nominating him for the 2026 Annual Meeting, and limiting Board size to 10 directors until the 2026 Annual Meeting and 9 thereafter until the Expiration Date. Vision One Parties agreed to withdraw their 2026 Annual Meeting nominees, adhere to standstill restrictions, and vote for Board nominees. No financial terms or impacts were disclosed.

  • ·Board size limited to no more than 10 directors until 2026 Annual Meeting and 9 directors from 2026 Annual Meeting until Expiration Date (earlier of 30 days prior to 2027 stockholder nomination deadline or 150 days prior to 2026 Annual Meeting one-year anniversary).
  • ·Neal J. Keating, age 70, previously Chairman, President, and CEO of Kaman Corporation (2008-2020), Executive Chairman until 2021; COO of Hughes Supply; CEO of GKN Aerospace.
  • ·Mr. Keating serves on Hubbell Incorporated board since 2010 (chairs nominating/governance committee); former lead director of Triumph Group (2022-July 2025) and Barnes Group Inc. (2023-2025).
  • ·No arrangements or understandings other than Cooperation Agreement for appointment; no reportable related party transactions under Item 404(a).
SELECT MEDICAL HOLDINGS CORPDEFA14Aneutralmateriality 8/10

04-03-2026

Select Medical Holdings Corporation (SEM) issued definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders on April 23, 2026, at 11:00am ET virtually. Key proposals include election of Class II directors, advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as auditors for FY 2026, amendment to phase out the classified board structure, and competing advisory votes on special meeting rights at 25% (company) vs. 10% (stockholder) ownership thresholds. The Board recommends FOR proposals 1-5 and AGAINST the stockholder proposal 6; materials available online with paper requests due by April 13, 2026.

  • ·Virtual meeting access: https://meetnow.global/MKMHXJW
  • ·Online materials: www.envisionreports.com/SEM
  • ·Phone for requests: 1-866-641-4276
  • ·Email for requests: investorvote@computershare.com
COCA-COLA EUROPACIFIC PARTNERS plc6-Kneutralmateriality 4/10

04-03-2026

Coca-Cola Europacific Partners plc (CCEP) announced that Independent Non-executive Director Guillaume Bacuvier will retire from the Board at the conclusion of the Annual General Meeting (AGM) on 28 May 2026, after serving since January 2024. Uvashni Raman, current CFO of Booking.com, has been appointed as a new Independent Non-executive Director effective the same date, bringing extensive financial and operational experience from roles at Adevinta, Naspers, South 32, and BHP. The changes are part of the Board's succession planning.

  • ·Guillaume Bacuvier served on the Remuneration Committee.
  • ·Uvashni Raman's prior roles: Group CFO of Adevinta (2019-2023), CFO for Naspers Video Entertainment Division (2016-2019), South 32 Australian Region (2015-2016), multiple roles at BHP.
  • ·CCEP listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, Spanish Stock Exchanges; constituent of NASDAQ 100 and FTSE 100.
MOODYS CORP /DE/DEF 14Aneutralmateriality 6/10

04-03-2026

Moody’s Corporation's 2026 Proxy Statement outlines the virtual Annual Meeting of Stockholders on April 14, 2026, at 9:30 a.m. EDT, with stockholders voting on electing ten director nominees for one-year terms, ratifying KPMG LLP as independent auditors for 2026, and an advisory resolution on executive compensation. The record date is February 18, 2026, and proxy materials were made available starting March 4, 2026. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

  • ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/MCO2026
  • ·Company address: 7 World Trade Center, 250 Greenwich Street, New York, New York 10007
  • ·Investor Relations contact: ir@moodys.com or (212) 553-0300
  • ·2025 Annual Report covers year ended December 31, 2025
MOODYS CORP /DE/DEFA14Aneutralmateriality 6/10

04-03-2026

Moody's Corporation filed DEFA14A additional proxy materials on March 4, 2026, for its 2026 Annual Meeting scheduled virtually on April 14, 2026, at 9:30 a.m. EDT. Shareholders are asked to vote on the election of 10 director nominees, ratification of KPMG LLP as the independent auditor for 2026, and an advisory approval of executive compensation, with voting deadline of April 13, 2026, 11:59 p.m. EDT. Proxy materials are available online at www.ProxyVote.com, with requests for paper copies due by March 31, 2026.

  • ·Meeting location: Virtually at www.virtualshareholdermeeting.com/MCO2026
  • ·Company address: 7 World Trade Center, 250 Greenwich Street, New York, NY 10007
  • ·Material request methods: www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
United States 12 Month Natural Gas Fund, LP10-Kmixedmateriality 8/10

04-03-2026

UNL's net asset value per share declined 9.6% YoY to $7.34 at December 31, 2025, from $8.12, amid a 20.9% drop in average daily total net assets to $14.3M and ongoing net loss of $971k (narrowed 20% from $1.2M in 2024). While Partners’ Capital remained stable at $18.7M with slight 0.2% growth, total assets fell 1.2% to $18.8M and dividend/interest income decreased 35% to $586k with yield down to 4.09%. Commodity futures trading showed mixed results with $1.86M realized gains but $3.19M unrealized losses.

  • ·Unrealized loss on open commodity futures contracts: $(2.07M) at Dec 31 2025 vs gain $1.12M at Dec 31 2024.
  • ·Realized gain on closed commodity futures: $1.86M in 2025 vs loss $(7.41M) in 2024.
  • ·Net cash from operating activities: $1.95M in 2025 vs $(6.33M) in 2024.
  • ·Tax risk: Potential reallocation of income/gain items by IRS could make UNL liable for federal income tax.
Bankwell Financial Group, Inc.10-Kpositivemateriality 9/10

04-03-2026

Bankwell Financial Group, Inc. reported strong recovery in 2025 with net income surging 260% YoY to $35.2M from $9.8M in 2024, fueled by net interest income growth of 19% to $98.9M, total revenue up 25% to $108.3M, and provision for credit losses dropping sharply to $1.0M from $22.6M. Asset quality improved markedly with nonperforming assets to total assets at 0.49% versus 1.88% in 2024, and return on average assets rose to 1.09% from 0.31%. However, noninterest expenses increased 15% YoY to $58.8M due to higher salaries and professional services, while efficiency ratio improved modestly to 54.1% from 57.9%.

  • ·Provision for credit losses declined to $1.0M in 2025 from $22.6M in 2024.
  • ·Net (recoveries) charge-offs to average loans at -0.01% in 2025 vs 0.81% in 2024.
  • ·Tier 1 capital to risk-weighted assets for Bankwell Bank at 11.87% in 2025 (up from 11.64%).
  • ·Gains and fees from sales of loans jumped to $5.1M in 2025 from $0.5M in 2024.
Wheeler Real Estate Investment Trust, Inc.8-Kneutralmateriality 6/10

04-03-2026

On February 26, 2026, Wheeler Real Estate Investment Trust, Inc. issued 60,000 shares of common stock in exchange for 4,000 shares of Series B Convertible Preferred Stock and 2,000 shares of Series D Cumulative Convertible Preferred Stock from an unaffiliated holder, with the preferred shares retired and no cash proceeds received. Separately, the Company issued 80,000 shares of Series D Preferred Stock to an unaffiliated investor in exchange for 120,000 shares of subsidiary Cedar Realty Trust, Inc.'s Series C Cumulative Redeemable Preferred Stock, which were subsequently retired. Both transactions relied on Securities Act exemptions and do not constitute public offerings.

  • ·Transactions relied on Section 3(a)(9) exemption for common stock exchange and Section 4(a)(2) for Series D issuance as non-public offerings.
  • ·Each exchange transaction involved 30 shares of Common Stock for 2 shares of Series B Preferred and 1 share of Series D Preferred.
DIAMOND HILL INVESTMENT GROUP INC8-Kneutralmateriality 8/10

04-03-2026

Diamond Hill Investment Group, Inc. disclosed assets under management (AUM) totaling $28.072 billion as of February 28, 2026, for its wholly owned subsidiary Diamond Hill Capital Management, Inc. By investment vehicle, proprietary funds represented the largest portion at $17.754 billion, followed by separately managed accounts at $4.880 billion. By investment strategy, large cap strategies held $12.450 billion, while short duration securitized bond accounted for $5.321 billion.

  • ·Collective investment trusts AUM: $1.523B
  • ·Other pooled vehicles AUM: $3.915B
  • ·Small Cap strategy AUM: $288M
  • ·Core Fixed Income strategy AUM: $3.897B
Helmerich & Payne, Inc.8-Kpositivemateriality 6/10

04-03-2026

Helmerich & Payne, Inc. declared a quarterly cash dividend of $0.25 per share on its common stock at a Board of Directors meeting on March 4, 2026. The dividend is payable on June 1, 2026, to stockholders of record at the close of business on May 18, 2026.

  • ·Securities registered: Common Stock ($0.10 par value) under ticker HP on NYSE
HAIN CELESTIAL GROUP INC8-Kpositivemateriality 8/10

04-03-2026

Hain Celestial Group (Nasdaq: HAIN) completed the sale of its North American Snacks business, including Garden Veggie Snacks™, Terra® chips, and Garden of Eatin'® snacks, to Snackruptors Inc. Proceeds from the transaction will be used to reduce debt, strengthening the company's financial position and leverage profile. The divestiture sharpens focus on higher-margin core categories such as yogurt, tea, and baby & kids foods, with retained global brands including Celestial Seasonings® teas, The Greek Gods® yogurt, Earth's Best® Organic, and Ella's Kitchen®.

  • ·Headquartered in Hoboken, N.J.
  • ·Products marketed and sold in over 70 countries.
  • ·Filing Date: March 04, 2026; Announcement Date: March 2, 2026
Edgemode, Inc.8-Kneutralmateriality 5/10

04-03-2026

Edgemode, Inc. entered into a securities purchase agreement on February 24, 2026, issuing a convertible promissory note with a $150,000 principal amount and $15,000 original issuance discount to CFI Capital LLC, receiving net proceeds of $130,000 after $5,000 in legal costs for working capital. The note accrues 6% annual interest payable in shares, matures on February 24, 2027, and becomes convertible after six months at 60% of the lowest trading price over the prior 15 trading days, with a 9.99% ownership cap. Standard events of default apply, potentially adjusting the conversion price to 45%.

  • ·Promissory note prepayment subject to penalties and premiums.
  • ·Issued in reliance on Section 4(a)(2) exemption from Securities Act registration.
  • ·Events of default include failure to honor conversion notices, SEC reporting delays, or delisting from OTC Markets.
FEDERAL AGRICULTURAL MORTGAGE CORP8-Kneutralmateriality 4/10

04-03-2026

Federal Agricultural Mortgage Corporation (Farmer Mac) issued a press release on March 4, 2026, announcing the date and time of its upcoming Investor Day webcast to discuss growth opportunities and strategic priorities. The filing lists various registered securities including Class A and Class C common stock and multiple series of preferred stock. No financial results or performance metrics were disclosed.

CRACKER BARREL OLD COUNTRY STORE, INC8-Kmixedmateriality 9/10

04-03-2026

Cracker Barrel Old Country Store, Inc. reported Q2 FY2026 total revenue of $874.8 million, down 7.9% YoY from $949.4 million, driven by comparable store restaurant sales declining 7.1% and retail sales falling 9.2%. GAAP net income dropped to $1.3 million ($0.06 per diluted share) from $22.2 million ($0.99 per diluted share), with adjusted EBITDA decreasing to $38.2 million from $74.6 million. However, the company ended the quarter with total debt of $531.5 million and a low consolidated senior leverage ratio of 0.3x, expects a $46 million net cash benefit from litigation settlements in Q3, and updated its FY2026 outlook to $3.24-3.27 billion in revenue and $85-100 million adjusted EBITDA while declaring a $0.25 quarterly dividend.

  • ·Six months FY2026 net loss of $23.3 million vs net income of $27.1 million prior year.
  • ·Q2 FY2026 operating income of $0.5 million vs $29.1 million prior year (-98%).
  • ·Capital expenditures outlook for FY2026: $105-115 million.
  • ·2 new Cracker Barrel stores planned for FY2026.
  • ·Quarterly dividend of $0.25 per share payable May 13, 2026 to shareholders of record April 10, 2026.
Costamare Inc.20-Fneutralmateriality 7/10

04-03-2026

Costamare Inc. discloses its containership fleet in its 20-F annual report filed on March 04, 2026, consisting of 69 operating vessels with capacities ranging from 1,078 to 14,424 TEU and charter expirations from October 2026 to March 2036, primarily with charterers like Evergreen, MSC, COSCO, and Maersk. Average daily charter rates are provided for select vessels, such as $40,613 for the 14,424 TEU TRITON and $34,881 for the 9,469 TEU SHANGHAI, with TEU-weighted durations up to 6.9 years. Additionally, 10 newbuildings of 3,100 TEU each are under construction, with deliveries scheduled from Q2 2027 to Q4 2028 and employment secured upon delivery.

  • ·Largest vessels: Five 14,424 TEU ships (TRITON, TITAN, TALOS, TAURUS, THESEUS) chartered to Evergreen, expiring 2036.
  • ·Earliest charter expirations: October 2026 (MAERSK PUELO, ARKADIA), with some extendable.
  • ·Many charter details confidential (marked with *) including rates and exact expirations.
  • ·Newbuilding deliveries: Q2-Q4 2027 (4 vessels), Q1-Q4 2028 (6 vessels), with long-term or medium-term employment.
PepGen Inc.10-Kmixedmateriality 9/10

04-03-2026

PepGen Inc. reported a slightly narrower net loss of $89.7M for the year ended December 31, 2025, compared to $90.0M in 2024, with operating expenses declining 4.2% YoY to $93.6M driven by a 7.1% drop in R&D expenses, though G&A rose 6.2%. Cash and equivalents grew 22.5% to $60.5M, bolstered by $108M net proceeds from a public offering, resulting in a net cash increase of $11.1M versus a $31.4M decrease prior year; however, interest income fell 43.7% to $4.0M and shares outstanding more than doubled to 68.9M, diluting EPS to $(2.12) from $(2.85). Total assets expanded 15.3% to $173.9M, but accumulated deficit widened to $361.1M.

  • ·Stock-based compensation expense declined to $10.6M from $11.5M YoY.
  • ·Net cash used in investing activities improved to $(15.2M) from $(37.7M), with lower purchases of marketable securities.
  • ·Accumulated deficit increased to $361.1M from $271.5M.
  • ·Employment agreements executed with executives on May 20, 2025 (Kasra Kasrarian, PhD), August 19, 2024 (Paul D. Streck), and December 8, 2025 (Joseph Vittiglio).
CRACKER BARREL OLD COUNTRY STORE, INC10-Qnegativemateriality 9/10

04-03-2026

For the quarter ended January 30, 2026, Cracker Barrel reported revenue of $875M, down 7.9% YoY from $949M, with net income falling sharply to $1.3M from $22.2M amid higher impairments and weak operating income of $0.5M versus $29.1M prior year. Six-month revenue declined 6.8% YoY to $1.67B, swinging to a $23.3M net loss from $27.1M profit, though G&A expenses dropped 22% YoY to $48M in the quarter. Total assets decreased to $2.10B from $2.16B at fiscal year-end, with cash equivalents falling to $8.6M from $39.6M.

  • ·Cash flows from operating activities for six months: -$2.2M vs $93.7M prior year.
  • ·Long-term debt increased to $382M from $335M sequentially.
  • ·Shareholders’ equity declined to $426M from $462M sequentially.
  • ·Property and equipment capex six months: $62M vs $77M prior year.
  • ·Dividends declared six months: $0.25 per share, total ~$12M.
PepGen Inc.8-Kmixedmateriality 8/10

04-03-2026

PepGen Inc. reported Q4 and FY 2025 financial results with cash of $148.5M sufficient into 2H 2027, R&D expenses down 27% YoY to $13.9M in Q4 and 7% to $71.0M for the year, and net loss narrowed to $18.3M in Q4 (from $22.2M) and $89.7M for the year (from $90.0M); however, G&A expenses rose 9% YoY to $5.9M in Q4, and an FDA partial clinical hold was placed on the FREEDOM2 trial. Clinical progress includes FREEDOM Phase 1 unblinded data showing dose-proportional splicing correction up to 53.7% at 15 mg/kg, dosing of 4/8 patients in the FREEDOM2 10 mg/kg cohort, and upcoming 5 mg/kg data in Q1 2026. Corporate highlights feature a new USPTO patent for PGN-EDODM1 into 2H 2042 and appointment of Joseph Vittiglio as Chief Business and Legal Officer.

  • ·FDA granted PGN-EDODM1 Orphan Drug and Fast Track Designations; EMA granted Orphan Designation.
  • ·Net loss per share: Q4 2025 $(0.27) vs 2024 $(0.68); FY 2025 $(2.12) vs 2024 $(2.85).
  • ·New USPTO composition of matter patent for PGN-EDODM1 provides exclusivity into 2H 2042, with potential extension.
  • ·FREEDOM2 5 mg/kg cohort data expected Q1 2026; 10 mg/kg cohort data expected 2H 2026; protocol amended for up to 12.5 mg/kg.
  • ·MDA Conference March 8–11, 2026, to present final FREEDOM-DM1 results.
Pulmonx Corp8-Kmixedmateriality 9/10

04-03-2026

Pulmonx reported full year 2025 worldwide revenue of $90.5 million, up 8% YoY (7% constant currency), driven by strong 23% international growth (19% CC), while U.S. revenue grew only 1%; however, Q4 revenue declined 5% YoY to $22.6 million (-7% CC), with U.S. down 11% and international up 8%. Gross margins improved to 78% in Q4 (from 74%) and held at 74% for the year, operating expenses fell 11% in Q4 but rose 1% for the year, and net losses narrowed to $54.0 million for FY2025 (from $56.4 million). FY2026 guidance projects flat revenue of $90-92 million, 75% gross margin, and $113-115 million operating expenses.

  • ·Cash, cash equivalents, and marketable securities decreased ~$32M YoY to $69.8M as of Dec 31, 2025.
  • ·Refinanced debt with up to $60M committed capital under 5-year interest-only facility maturing 2031.
  • ·FY2026 expected cash decrease of ~$23M assuming no additional credit facility drawdowns.
  • ·Adjusted EBITDA loss improved to $30.6M for FY2025 from $31.3M in FY2024.
MOZAYYX Acquisition Corp.8-Kpositivemateriality 10/10

04-03-2026

MOZAYYX Acquisition Corp., a blank check company, consummated its upsized initial public offering on February 26, 2026, of 30,000,000 units at $10.00 per unit, generating $300M in gross proceeds, including 3,900,000 units from partial over-allotment exercise. Simultaneously, it completed a private placement of 3,610,000 warrants for $7.22M to its sponsor and Cantor Fitzgerald & Co. The balance sheet as of February 26 reflects $301.64M total assets with $300M in trust, but shows a $11.38M shareholders' deficit and $13.02M liabilities primarily from deferred underwriting fees of $12.78M.

  • ·Of private placement warrants: 2,305,000 to sponsor and 1,305,000 to Cantor Fitzgerald & Co.
  • ·Prepaid expenses: $10,500; Related party payable: $142,934; Accrued expenses: $98,115.
  • ·Class B ordinary shares include up to 375,000 subject to forfeiture related to over-allotment.
LITHIA MOTORS INC8-Kpositivemateriality 8/10

04-03-2026

Lithia Motors, Inc. entered into the Seventh Amendment to its Fourth Amended and Restated Loan Agreement on February 27, 2026, extending the credit facility's expiration date to February 27, 2031, with annual 1-year extension options subject to lender consent and conditions. The amendment introduces VIN-specific reporting for Used Vehicle and Service Loaner Floorplan facilities (upon company election) and reallocates commitments to $2.7B for New Vehicle Floorplan, $1.25B for Used Vehicle Floorplan, $150M for Service Loaner Floorplan, and $2.4B for Revolving Line of Credit. It also removes the Simple SOFR Adjustment.

  • ·Original Loan Agreement dated April 29, 2021
  • ·Filing submitted on March 4, 2026
ACTELIS NETWORKS INCDEF 14Aneutralmateriality 8/10

04-03-2026

Actelis Networks, Inc. is convening a special stockholder meeting on April 13, 2026, at 10:00 a.m. EST in Petach Tikva, Israel, to vote on three proposals: (1) authorizing issuance of common stock under the ELOC Purchase Agreement per Nasdaq Listing Rule 5635(d), (2) approving a reverse stock split amendment at a 1-for-10 to 1-for-25 ratio to be determined by the Board, and (3) approving adjournment if needed for additional solicitation. The record date is February 13, 2026, with 8,759,402 shares outstanding requiring a quorum of 2,919,801 shares (one-third). The Board recommends voting FOR all proposals, with proxies solicited by CEO Tuvia Barlev and CFO Yoav Efron.

  • ·Common stock par value: $0.0001 per share
  • ·Proxy materials mailed on or about March 4, 2026
  • ·Meeting location: 25 Bazel Street, Petach Tikva, Israel 4950138
  • ·Transfer agent: Vstock Transfer, LLC
Stellar V Capital Corp. (Cayman Islands)8-Kneutralmateriality 5/10

04-03-2026

Stellar V Capital Corp., a blank check company, elected Michael Braunstein as a class II director on February 28, 2026, to fill the vacancy left by his father Harry Braunstein, who passed away on November 2, 2025. Michael Braunstein, deemed independent under NASDAQ rules, will serve on the Audit Committee and Compensation Committee and chair the Nominating and Corporate Governance Committee. The appointment was recommended by the Nominating and Governance Committee.

  • ·Michael Braunstein has been a partner of Braunstein Turkish LLP since September 2009 and managing member of Sunset Capital 1 LLC and affiliates since November 2025.
  • ·From January 2024 to November 2025, Michael Braunstein was president of Sunset Capital 1 LLC and affiliates; from January 2019 to December 2023, vice president.
  • ·Michael Braunstein holds a bachelor’s degree in music business from New York University (2004) and Juris Doctor from Brooklyn Law School (2009).
KOHLS Corp8-Kpositivemateriality 4/10

04-03-2026

Kohl’s Corporation promoted Mari Steinmetz to Senior Executive Vice President, Chief People Officer, effective February 27, 2026, and designated her as an executive officer. She has served in the EVP role since March 2023, joined the company in 2010, and previously held progressive HR leadership positions including Senior Vice President of Benefits, Compensation, Talent Management, People Analytics, and HR Business Partners. Ms. Steinmetz brings more than 20 years of retail and human resources experience, including prior roles at Target.

  • ·Ms. Steinmetz will continue to lead talent, culture, human resources, recruitment, associate development, relations, compensation, benefits, and organizational culture.
  • ·Filed on March 4, 2026, reporting event of February 27, 2026.
PepGen Inc.8-Kneutralmateriality 3/10

04-03-2026

PepGen Inc. filed an 8-K on March 4, 2026, under Items 7.01 and 9.01, announcing an update to its Corporate Presentation as of March 2026, furnished as Exhibit 99.1. The filing specifies that the information is not deemed 'filed' and is not an admission of materiality.

Ellington Credit Co8-Kmixedmateriality 9/10

04-03-2026

Ellington Credit Company (EARN) reported a Q3 FY26 GAAP net loss of $21.1 million ($0.56 per share), driven by $27.5 million in unrealized losses on investments (primarily CLO equity) and $2.0 million in credit hedge losses, despite net investment income of $7.8 million ($0.21 per share) and $19.1 million in recurring cash distributions ($0.51 per share). NAV per share declined to $5.19, with the CLO portfolio at $369.5 million fair value (down from amortized cost of $395.7 million). QoQ, total investment income fell 3% to $13.7 million and NII declined 9% to $7.8 million, while net income swung sharply from a $4.3 million profit to a loss.

  • ·Monthly distributions declared at $0.08 per share from Oct 2025 to Mar 2026.
  • ·Conference call scheduled for March 5, 2026 at 11:00 a.m. ET.
  • ·Investor presentation posted on www.ellingtoncredit.com.
ClearSign Technologies Corp8-Kmixedmateriality 7/10

04-03-2026

ClearSign Technologies Corporation held a special stockholder meeting on February 26, 2026, with a quorum of 35,968,485 shares present or by proxy, representing 67.09% of outstanding voting shares. Shareholders approved Proposal 1 to amend the certificate of incorporation for a potential reverse stock split (1-for-2 to 1-for-10) at board discretion to comply with Nasdaq rules (26,667,027 for; 9,224,242 against; 77,216 abstentions), and Proposal 2 to approve adjournments (27,887,899 for; 7,865,883 against; 214,703 abstentions), though both saw significant opposition votes exceeding 20%. The company announced its 2026 annual meeting for June 8, 2026 (record date April 13, 2026), with stockholder proposal deadlines of March 14, 2026.

  • ·Special meeting record date: January 22, 2026.
  • ·Definitive proxy statement filed with SEC on February 2, 2026.
  • ·Annual meeting record date: April 13, 2026.
  • ·Stockholder proposals under Rule 14a-8 and bylaws nominations due by close of business March 14, 2026.
  • ·Common stock par value: $0.0001 per share.
  • ·No broker non-votes on either proposal.
XWELL, Inc.8-Kneutralmateriality 8/10

04-03-2026

XWELL, Inc. designated 35,000 shares of Series H Convertible Preferred Stock with a stated value of $1,000 per share (total $35M) and an initial conversion price of $0.47 into common stock, adopted by the Board on February 26, 2026, pursuant to a Securities Purchase Agreement dated February 24, 2026. The preferred stock is immediately convertible at the holder's option, subject to a 4.99% beneficial ownership limitation (increaseable to 9.99%). No financial performance metrics or period comparisons are provided in the filing.

  • ·Certificate of Designation filed as EX-3.1 with 8-K on March 04, 2026
  • ·Conversion shares issuable: Stated Value divided by Conversion Price
  • ·Delivery of conversion shares required within 5 business days
  • ·Adjustments to Conversion Price for stock splits, combinations, or reclassifications
  • ·No dividends on Series H Preferred Stock unless consented by Required Holders and paid pro rata as-if-converted
FARADAY FUTURE INTELLIGENT ELECTRIC INC.8-Kneutralmateriality 4/10

04-03-2026

On February 26, 2026, Chui Tin Mok, an executive director on the Board of Faraday Future Intelligent Electric Inc., notified the Board of his intent to resign upon confirmation of a successor to focus on business execution in the UAE and Middle East. He will continue serving as an executive officer and Head of FF Middle East. The resignation has no immediate impact as no successor is yet named.

  • ·Trading symbols: FFAI (Class A common stock), FFAIW (redeemable warrants) on Nasdaq Stock Market LLC
  • ·Company confirmed as emerging growth company
  • ·Business address: 18455 S. Figueroa Street, Gardena, CA 90248
  • ·Former name: Property Solutions Acquisition Corp. (changed March 4, 2020)

Get daily alerts with 12 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →
S&P 500 Consumer Staples Sector SEC Filings — March 04, 2026 | Gunpowder Blog